Addressing Practical Challenges in HCV Management
  • Program Overview
    Addressing Practical Challenges in HCV Management
    In this program, which includes an on-demand multimedia module combining the slides and audio from a live symposium presented at the 2016 annual meeting of the AASLD in Boston, Massachusetts, gain multidisciplinary expert perspectives on best practices in addressing challenging issues in HCV management.
  • Featured content
    In this downloadable slideset, Sherilyn C. Brinkley, MSN, CRNP; Jordan J. Feld, MD, MPH; Jason Grebely, BSc, PhD; Nancy Reau, MD, FAASLD, AGAF; and Phoebe Sebhatu, PharmD, BCPS, review best practices in addressing practical aspects of managing patients with HCV, including interpretation of current guidelines and payer policies, approaches to patient education and engagement in care, specialty pharmacy utilization and navigation of the insurance appeals process, and management of drug users and patients who become reinfected.
    Date Posted: 11/28/2016
  • 1
  • 2

Latest Content

2 of 2 Shown
  • Addressing Practical Challenges in HCV Management

    In this on-demand multimedia module combining slides and audio from a live symposium presented at the 2016 annual meeting of the AASLD in Boston, Massachusetts, multidisciplinary expert faulty provide their perspectives on practical aspects of managing patients with HCV, including interpretation of current guidelines and payer policies, approaches to patient engagement in care, specialty pharmacy utilization and navigation of the insurance appeals process, and management of people who inject drugs.
    Date Posted: 12/20/2016
  • Addressing Practical Challenges in HCV Management

    In this downloadable slideset, Sherilyn C. Brinkley, MSN, CRNP; Jordan J. Feld, MD, MPH; Jason Grebely, BSc, PhD; Nancy Reau, MD, FAASLD, AGAF; and Phoebe Sebhatu, PharmD, BCPS, review best practices in addressing practical aspects of managing patients with HCV, including interpretation of current guidelines and payer policies, approaches to patient education and engagement in care, specialty pharmacy utilization and navigation of the insurance appeals process, and management of drug users and patients who become reinfected.
    Date Posted: 11/28/2016
2 of 2 Shown
Show 0 More
Loading...